These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 10596840)
1. Plasma and tissue kallikrein in arthritis and inflammatory bowel disease. Colman RW Immunopharmacology; 1999 Sep; 43(2-3):103-8. PubMed ID: 10596840 [TBL] [Abstract][Full Text] [Related]
2. The role of plasma high molecular weight kininogen in experimental intestinal and systemic inflammation. Isordia-Salas I; Pixley RA; Sáinz IM; Martínez-Murillo C; Colman RW Arch Med Res; 2004; 35(5):369-77. PubMed ID: 15610905 [TBL] [Abstract][Full Text] [Related]
3. The role of plasma high molecular weight kininogen in experimental intestinal and systemic inflammation. Isordia-Salas I; Pixley RA; Sáinz IM; Martínez-Murillo C; Colman RW Arch Med Res; 2005; 36(1):87-95. PubMed ID: 15900628 [TBL] [Abstract][Full Text] [Related]
4. Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: modulation by a selective plasma kallikrein inhibitor. Colman RW; Stadnicki A; Kettner CA; Adam AA; DeLa Cadena RA; Sartor RB Proc Assoc Am Physicians; 1997 Jan; 109(1):10-22. PubMed ID: 9010912 [TBL] [Abstract][Full Text] [Related]
5. Localization and secretion of tissue kallikrein in peptidoglycan-induced enterocolitis in Lewis rats. Stadnicki A; Chao J; Stadnicka I; Van Tol E; Lin KF; Li F; Sartor RB; Colman RW Am J Physiol; 1998 Oct; 275(4):G854-61. PubMed ID: 9756518 [TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible rats. Stadnicki A; Sartor RB; Janardham R; Majluf-Cruz A; Kettner CA; Adam AA; Colman RW FASEB J; 1998 Mar; 12(3):325-33. PubMed ID: 9506476 [TBL] [Abstract][Full Text] [Related]
7. Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers. Devani M; Cugno M; Vecchi M; Ferrero S; Di Berardino F; Avesani EC; de Franchis R; Colman RW Am J Gastroenterol; 2002 Aug; 97(8):2026-32. PubMed ID: 12190172 [TBL] [Abstract][Full Text] [Related]
8. [High molecular weight kininogen in inflammation and angiogenesis: a review of its properties and therapeutic applications]. Isordia-Salas I; Sainz IM; Pixley RA; Martínez-Murillo C; Colman RW Rev Invest Clin; 2005; 57(6):802-13. PubMed ID: 16708906 [TBL] [Abstract][Full Text] [Related]
9. Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis rat. Stadnicki A; DeLa Cadena RA; Sartor RB; Bender D; Kettner CA; Rath HC; Adam A; Colman RW Dig Dis Sci; 1996 May; 41(5):912-20. PubMed ID: 8625762 [TBL] [Abstract][Full Text] [Related]
10. Role of kallikrein-kinin system in pathogenesis of bacterial cell wall-induced inflammation. DeLa Cadena RA; Laskin KJ; Pixley RA; Sartor RB; Schwab JH; Back N; Bedi GS; Fisher RS; Colman RW Am J Physiol; 1991 Feb; 260(2 Pt 1):G213-9. PubMed ID: 1996642 [TBL] [Abstract][Full Text] [Related]
11. Tissue and plasma kallikrein in inflammatory bowel disease. Stadnicki A Dig Liver Dis; 2005 Sep; 37(9):648-50. PubMed ID: 15963774 [No Abstract] [Full Text] [Related]
12. Selective kallikrein-kinin system activation in inbred rats differentially susceptible to granulomatous enterocolitis. Sartor RB; DeLa Cadena RA; Green KD; Stadnicki A; Davis SW; Schwab JH; Adam AA; Raymond P; Colman RW Gastroenterology; 1996 May; 110(5):1467-81. PubMed ID: 8613052 [TBL] [Abstract][Full Text] [Related]
13. Intestinal tissue kallikrein-kinin system in inflammatory bowel disease. Stadnicki A Inflamm Bowel Dis; 2011 Feb; 17(2):645-54. PubMed ID: 20848521 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of plasma kallikrein prevents peptidoglycan-induced arthritis in the Lewis rat. Dela Cadena RA; Stadnicki A; Uknis AB; Sartor RB; Kettner CA; Adam A; Colman RW FASEB J; 1995 Mar; 9(5):446-52. PubMed ID: 7896018 [TBL] [Abstract][Full Text] [Related]